Quick Answer
NEUROCRINE BIOSCIENCES INC reported R&D Expense of $160.52 million for fiscal year 2018.
NEUROCRINE BIOSCIENCES INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2018 | $160.52M | +31.8% |
| 2017 | $121.83M | +29.2% |
| 2016 | $94.29M | +15.7% |
| 2015 | $81.49M | +75.5% |
| 2014 | $46.42M | +18.3% |
| 2013 | $39.25M | +5.6% |
| 2012 | $37.16M | +20.1% |
| 2011 | $30.95M | -0.6% |
| 2010 | $31.15M | -7.6% |
| 2009 | $33.72M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2021 | $73.20M | +25.6% | +25.6% |
| March 31, 2020 | $58.30M | +54.8% | -5.5% |
| June 30, 2019 | $61.69M | +66.8% | +63.8% |
| March 31, 2019 | $37.65M | -23.1% | +6.1% |
| September 30, 2018 | $35.48M | +58.0% | -4.1% |
| June 30, 2018 | $36.99M | +69.1% | -24.4% |
| March 31, 2018 | $48.95M | -5.7% | +117.9% |
| September 30, 2017 | $22.46M | +7.3% | +2.7% |
- NEUROCRINE BIOSCIENCES INC showed an increase of +31.8% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2018 period, NEUROCRINE BIOSCIENCES INC’s r&d expense has grown by 376.0% (from $33.72 million to $160.52 million).
- The most recent figure is from NEUROCRINE BIOSCIENCES INC’s fiscal year 2018 report (Form 10-K), filed with the SEC on February 8, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: